Ontology highlight
ABSTRACT:
SUBMITTER: Moradi-Kalbolandi S
PROVIDER: S-EPMC4976644 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
Moradi-Kalbolandi Shima S Habibi-Anbouhi Mahdi M Golkar Majid M Behdani Mahdi M Rezaei Gashin G Ghazizadeh Leila L Abolhassani Mohsen M Shokrgozar Mohammad Ali MA
Data in brief 20160715
Current therapies for acute myeloid leukemia (AML), are associated with high relapse rates. Hence, development of new therapeutic strategies is crucial to circumvent this problem. Bivalent antibody technology has been used to engineer novel antibody fragments with increased avidity, by assembling two scFv in a single molecule. Here, we present accompanying data from construction and characterization experiments of a biscFv antibody targeting CD123, the most important biomarker of leukemic cancer ...[more]